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In the original publication of this paper, there is an error in Figure 2G. The representative Western blot image of the beta-actin loading
control for the blot in Figure 2G was mistakenly a duplication of the beta-actin blot from a different experiment that appears in
Figure 4D. The analysis of the data was done using the correct beta-actin loading control. This error in figure preparation does
not change the results or interpretation of the study. We have corrected the representative Western blot image of beta-actin, and
the correct version of Figure 2G is shown below. Figure 4D is correct, and the remainder of the original Figure 2 and the accompa-
nying text in the legend to Figure 2G require no further correction.
We would also like to clarify the figure legends of Figures 2, 4C–4E, S1B, S3A, and S3B. Western blots were developed using the
Odyssey Imaging System (LI-COR Biosciences), which allows detection of multiple primary antibodies probed on the same blot.
Thus, the beta-actin loading controls are the same for two different primary antibodies—for example, Figures 2A and 4C.0
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Figure 2. Biochemical Characterization of Tau Pathology Reveals Age-Dependent Increase in Tau Hyperphosphorylation and Presence of
Sarkosyl-Insoluble Tau in rTgTauEC
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